These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1975620)

  • 1. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
    Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
    Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
    Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
    Brooks DP; Mitchell MP; Short BG; Ruffolo RR; Nichols AJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1243-7. PubMed ID: 1675291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ; Koster PF; Brooks DP; Ruffolo RR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI; Smith GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM
    Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
    Eades SC; Moore JN
    Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS; Ricci A; Amenta F; Lokhandwala MF
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fenoldopam on cecal blood flow and mechanical activity in horses.
    Clark ES; Moore JN
    Am J Vet Res; 1989 Nov; 50(11):1926-30. PubMed ID: 2575878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
    Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
    J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526.
    Ackerman DM; Blumberg AL; McCafferty JP; Sherman SS; Weinstock J; Kaiser C; Berkowitz B
    Fed Proc; 1983 Feb; 42(2):186-90. PubMed ID: 6130004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.